AROMASIN

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Finland, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AROMASIN contains one active pharmaceutical ingredient (API):

1 Exemestane
UNII NY22HMQ4BX - EXEMESTANE

Exemestane is an irreversible, steroidal aromatase inhibitor, structurally related to the natural substrate androstenedione.

Read about Exemestane

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AROMASIN Coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02BG06 Exemestane L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10103R, 8506Q
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522718030074417
Country: CA Health Products and Food Branch Identifier(s): 02242705
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00361689, 00706384, 00706409, 07639343, 07639366, 09000817, 09155046, 10941910
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 30067-12-11
Country: EE Ravimiamet Identifier(s): 1011148
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 161547
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 26698, 299778, 373745
Country: HK Department of Health Drug Office Identifier(s): 46969
Country: IE Health Products Regulatory Authority Identifier(s): 13710, 13712, 13726, 62894
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4011
Country: IT Agenzia del Farmaco Identifier(s): 034678033, 045700010
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291012F1022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004069
Country: MT Medicines Authority Identifier(s): MA505/02801
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 185M2000
Country: NG Registered Drug Product Database Identifier(s): 04-9994
Country: NL Z-Index G-Standaard, PRK Identifier(s): 54917
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 9445
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65092001
Country: SG Health Sciences Authority Identifier(s): 11398P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681308121004
Country: US FDA, National Drug Code Identifier(s): 0009-7663
Country: ZA Health Products Regulatory Authority Identifier(s): 35/21.12/0011

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.